| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | 99.94% |
| Purity(Neutralization titration) | min. 98.0 % |
| Specific rotation [a]20/D | -26.0 to -30.0 deg(C=0.34, H2O) |
| NMR | confirm to structure |
Active Pharmaceutical Ingredients
Didanosine
2′,3′-Dideoxyinosine; 9-(2,3-Dideoxy-β-D-ribofuranosyl)-6-oxopurine; 9-(2,3-Dideoxy-β-D-ribofuranosyl)hypoxanthine
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C10H12N4O3Â = 236.23 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 69655-05-6 |
| Unit | Price |
| 100 mg | 6250 |
| 500 mg | 11250 |
| 1 g | 21000 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
